SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

ALXN (ALXN) News

Follow ALXN (ALXN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol ALXN Asset equity Sector Markets 90 days 0 Last 182.41 Updated Jun 28, 2026, 08:02 PM UTC Open live news feed Open ALXN chart & news
M AstraZeneca Posts Positive Trial Results AstraZeneca's ALXN1850 shows favourable safety profile and meets key secondary endpoint in bone health in Mulberry Phase III trial EQUITY | Jun 28, 2026, 08:02 PM UTC